Microbial enzymes and cellular targets

Microbial enzymes and cellular targets constitute a broad and heterogeneous category of molecular entities within pathogenic microorganisms—including bacteria, viruses, fungi, and parasites—that are targeted by antimicrobial agents to treat infections (StatPearls: Antibiotics, 2023). These targets are typically essential for the microbe's survival or replication and include enzymes involved in cell wall biosynthesis (e.g., penicillin-binding proteins), nucleic acid synthesis (e.g., DNA gyrase, RNA polymerase), and protein synthesis (e.g., the 30S and 50S ribosomal subunits) (Nature Reviews Microbiology, 2017). By exploiting biochemical differences between microbes and human hosts, such as the presence of a peptidoglycan cell wall or unique ribosomal structures, drugs can achieve selective toxicity. However, the clinical utility of targeting these molecules is increasingly threatened by the rapid evolution of antimicrobial resistance, where microbes modify these targets or develop bypass mechanisms (WHO: Antimicrobial Resistance, 2021). Because this term refers to a collective group of thousands of distinct molecules across various domains of life rather than a single specific protein or receptor, it is considered a high-level classification rather than a discrete therapeutic target.

Other names

Pathogen targetsAntimicrobial targetsBacterial enzymesViral targetsFungal targetsMicrobial metabolic pathways

Inhibition of essential microbial processes including cell wall synthesis, protein synthesis, nucleic acid replication, and metabolic pathways through targeted binding to enzymes or structural components.